Sullivan Timothy Eugene — SEC Form 4 filings
SEC reporting owner CIK 1707000. 21 Form 4 filings on record with FilingPulse; latest filed 2026-05-14.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-01-17 to 2026-05-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 15 filings — 95,421 shares, $3,210,492 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 44.
- Largest priced transaction: sale of 32,729 shares @ $27.86 ($911,830) in Apellis Pharmaceuticals, Inc., filed 2025-09-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) | Chief Financial Officer | 21 | — | 17 legs · 95,421 sh · $3,210,492 | 44 |
Form 4 filings — Sullivan Timothy Eugene
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-14 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Code (U): 140,945 · Code (U): 71,492 · Grant/award (A): 41,250 · Disposition to issuer (D): 41,250 · Grant/award (A): 30,620 · Disposition to issuer (D): 30,620 · +17 more | EDGAR |
| 2026-04-20 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Gift (G): 11,096 @ $0 · Gift (G): 11,096 @ $0 | EDGAR |
| 2026-01-30 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/award (A): 58,140 @ $0 | EDGAR |
| 2026-01-23 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 10,287 @ $21.77 | EDGAR |
| 2026-01-21 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 2,892 @ $19.79 | EDGAR |
| 2026-01-15 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 3,856 @ $22.19 | EDGAR |
| 2025-10-23 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 10,000 @ $10.03 · Sale (S): 10,000 @ $28.03 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 15,000 @ $10.03 · Sale (S): 32,729 @ $27.86 · Sale (S): 10,000 @ $27.83 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/award (A): 82,500 (derivative) @ $19.39 | EDGAR |
| 2025-01-30 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 546 @ $29.52 | EDGAR |
| 2025-01-23 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 3,088 @ $30.43 | EDGAR |
| 2025-01-21 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 1,730 @ $29.96 · Grant/award (A): 45,929 @ $0 | EDGAR |
| 2025-01-14 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 2,170 @ $28.70 | EDGAR |
| 2025-01-03 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 1,042 @ $14.95 · Option exercise (M): 10,054 @ $13.85 · Option exercise (M): 1,042 (derivative) @ $0 · Option exercise (M): 10,054 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Gift (G): 14,164 @ $0 · Gift (G): 14,164 @ $0 | EDGAR |
| 2024-04-02 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 4,000 @ $10.03 · Sale (S): 4,000 @ $58.66 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 6,000 @ $10.03 · Sale (S): 4,000 @ $62.86 · Sale (S): 2,000 @ $63.95 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 1,431 @ $67.77 | EDGAR |
| 2024-01-31 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 906 @ $64.14 | EDGAR |
| 2024-01-23 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 3,551 @ $65.00 | EDGAR |
| 2024-01-17 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/award (A): 23,748 @ $0 · Sale (S): 2,235 @ $66.81 · Grant/award (A): 34,533 (derivative) @ $66.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1707000 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →